Novel therapeutic strategies based on toll-like receptor signaling

By Lawton J.A.   Ghosh P.  

Current Opinion in Chemical Biology, Vol. 7, Iss. 4, 2003-08 ,pp. : 446-451

Elsevier

Access to resources Recommend Favorite

Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling

By Matsumoto M.   Kikkawa S.   Kohase M.   Miyake K.   Seya T.  

Biochemical and Biophysical Research Communications, Vol. 293, Iss. 5, 2002-05 ,pp. : 1364-1369

Elsevier

Access to resources Recommend Favorite

Regulatory Roles for CD14 and Phosphatidylinositol in the Signaling via Toll-like Receptor 4-MD-2

By Akashi S.   Ogata H.   Kirikae F.   Kirikae T.   Kawasaki K.   Nishijima M.   Shimazu R.   Nagai Y.   Fukudome K.   Kimoto M.   Miyake K.  

Biochemical and Biophysical Research Communications, Vol. 268, Iss. 1, 2000-02 ,pp. : 172-177

Elsevier

Access to resources Recommend Favorite

Modulation of toll-like receptor function has therapeutic potential in autoimmune disease

By Clanchy Felix IL   Sacre Sandra M  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 12, 2010-12 ,pp. : 1703-1716

Informa Healthcare

Access to resources Recommend Favorite

Heterogeneous Expression of Toll-like Receptor 4 and Downregulation of Toll-like Receptor 4 Expression on Human Gingival Fibroblasts by Porphyromonas gingivalis Lipopolysaccharide

By Wang P-L.   Oido-Mori M.   Fujii T.   Kowashi Y.   Kikuchi M.   Suetsugu Y.   Tanaka J.   Azuma Y.   Shinohara M.   Ohura K.  

Biochemical and Biophysical Research Communications, Vol. 288, Iss. 4, 2001-11 ,pp. : 863-867

Elsevier

Access to resources Recommend Favorite